Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.

MLA

Pircher, Andreas, et al. “Neoadjuvant Chemo-Immunotherapy Modifies CD4(+)CD25(+) Regulatory T Cells (Treg) in Non-Small Cell Lung Cancer (NSCLC) Patients.” Lung Cancer (Amsterdam, Netherlands), vol. 85, no. 1, July 2014, pp. 81–87. EBSCOhost, https://doi.org/10.1016/j.lungcan.2014.04.001.

APA

Pircher, A., Gamerith, G., Amann, A., Reinold, S., Popper, H., Gächter, A., Pall, G., Wöll, E., Jamnig, H., Gastl, G., Wolf, A. M., Hilbe, W., & Wolf, D. (2014). Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients. Lung Cancer (Amsterdam, Netherlands), 85(1), 81–87. https://doi.org/10.1016/j.lungcan.2014.04.001

Chicago

Pircher, Andreas, Gabriele Gamerith, Arno Amann, Susanne Reinold, Helmut Popper, Anneliese Gächter, Georg Pall, et al. 2014. “Neoadjuvant Chemo-Immunotherapy Modifies CD4(+)CD25(+) Regulatory T Cells (Treg) in Non-Small Cell Lung Cancer (NSCLC) Patients.” Lung Cancer (Amsterdam, Netherlands) 85 (1): 81–87. doi:10.1016/j.lungcan.2014.04.001.